These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8103666)
1. Transforming growth factor-beta distribution in basal cell carcinomas: relationship to proliferation index. Stamp GW; Nasim M; Cardillo M; Sudhindra SG; Lalani EN; Pignatelli M Br J Dermatol; 1993 Jul; 129(1):57-64. PubMed ID: 8103666 [TBL] [Abstract][Full Text] [Related]
2. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Schmid P; Itin P; Rufli T Br J Dermatol; 1996 Jun; 134(6):1044-51. PubMed ID: 8763422 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma. Verhaegh ME; Arends JW; Majoie IM; Hoekzema R; Neumann HA Dermatol Surg; 1997 Aug; 23(8):695-700. PubMed ID: 9256917 [TBL] [Abstract][Full Text] [Related]
4. Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Glick AB; Kulkarni AB; Tennenbaum T; Hennings H; Flanders KC; O'Reilly M; Sporn MB; Karlsson S; Yuspa SH Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6076-80. PubMed ID: 7687059 [TBL] [Abstract][Full Text] [Related]
5. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. Kane CJ; Hebda PA; Mansbridge JN; Hanawalt PC J Cell Physiol; 1991 Jul; 148(1):157-73. PubMed ID: 1907288 [TBL] [Abstract][Full Text] [Related]
6. Lack of transforming growth factor-beta 1 expression in benign skin tumors of p53null mice is prognostic for a high risk of malignant conversion. Cui W; Kemp CJ; Duffie E; Balmain A; Akhurst RJ Cancer Res; 1994 Nov; 54(22):5831-6. PubMed ID: 7954410 [TBL] [Abstract][Full Text] [Related]
7. Growth and antigenic characteristics of basal cell carcinoma in culture. Bradbeer M; Bourne AJ; Ayberk H; Tang SK; Marks R Arch Dermatol Res; 1988; 280(4):228-34. PubMed ID: 2466442 [TBL] [Abstract][Full Text] [Related]
8. Distribution of beta 1, alpha 1, alpha 2 and alpha 3 integrin chains in basal cell carcinomas. Stamp GW; Pignatelli M J Pathol; 1991 Apr; 163(4):307-13. PubMed ID: 2033490 [TBL] [Abstract][Full Text] [Related]
9. Expression of Basigin in human fetal, infantile and adult skin and in basal cell carcinoma. Chen X; Kanekura T; Kanzaki T J Cutan Pathol; 2001 Apr; 28(4):184-90. PubMed ID: 11426825 [TBL] [Abstract][Full Text] [Related]
10. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602 [TBL] [Abstract][Full Text] [Related]
11. Expression of beta-catenin in basal cell carcinoma. El-Bahrawy M; El-Masry N; Alison M; Poulsom R; Fallowfield M Br J Dermatol; 2003 May; 148(5):964-70. PubMed ID: 12786827 [TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas. Hagedorn H; Sauer U; Schleicher E; Nerlich A Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385 [TBL] [Abstract][Full Text] [Related]
13. Comparison of PTCH1, COX-2, p53, and Ki-67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk. Khalesi M; Waterhouse M; Whiteman DC; Johns R; Rosendahl C; Hackett T; Pollak T; Kimlin MG; Hacker E; Neale RE; Int J Dermatol; 2016 Oct; 55(10):1096-105. PubMed ID: 27126210 [TBL] [Abstract][Full Text] [Related]
15. Differential patterns of placental and epithelial cadherin expression in basal cell carcinoma and in the epidermis overlying tumours. Pizarro A; Gamallo C; Benito N; Palacios J; Quintanilla M; Cano A; Contreras F Br J Cancer; 1995 Aug; 72(2):327-32. PubMed ID: 7640213 [TBL] [Abstract][Full Text] [Related]
16. Expression of proliferating cell nuclear antigen in basal cell carcinomas and in squamous cell carcinomas of canine skin: correlation with mitotic index and histological features. Maiolino P; Restucci B; De Vico G Zentralbl Veterinarmed A; 1995 Jul; 42(5):339-43. PubMed ID: 8578908 [TBL] [Abstract][Full Text] [Related]
17. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Marsh D; Dickinson S; Neill GW; Marshall JF; Hart IR; Thomas GJ Cancer Res; 2008 May; 68(9):3295-303. PubMed ID: 18451156 [TBL] [Abstract][Full Text] [Related]
18. Growth kinetic study of human hepatocellular carcinoma using proliferating cell nuclear antigen and Lewis Y antigen: their correlation with transforming growth factor-alpha and beta 1. Yamaguchi M; Yu L; Hishikawa Y; Yamanoi A; Kubota H; Nagasue N Oncology; 1997; 54(3):245-51. PubMed ID: 9143407 [TBL] [Abstract][Full Text] [Related]
19. Merkel cells are absent in basal cell carcinomas but frequently found in trichoblastomas. An immunohistochemical study. Schulz T; Hartschuh W J Cutan Pathol; 1997 Jan; 24(1):14-24. PubMed ID: 9027628 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of proliferating cell nuclear antigen/cyclin in human skin. Furukawa F; Imamura S; Fujita M; Kinoshita K; Yoshitake K; Brown WR; Norris DA Arch Dermatol Res; 1992; 284(2):86-91. PubMed ID: 1351713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]